The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Inflammatory Markers and Risk of Type 2 Diabetes
Open accessAbstract
OBJECTIVE: There has been growing evidence that inflammatory markers play a role in the development of type 2 diabetes. We aimed to systematically review prospective studies on the associations of elevated levels of interleukin-6 (IL-6) and C-reactive protein (CRP) with increased risk of type 2 diabetes by conducting a meta-analysis. RESEARCH DESIGN AND METHODS: A systematic search of the PubMed, EMBASE, ISI Web of Knowledge, and Cochrane Library databases up until 10 February 2012 was conducted to retrieve prospective studies matched to search terms. We used generalized least-squares trend estimation to assess dose-response relationships. The summary risk estimates were pooled using either fixed-effects or random-effects models to incorporate between-study variation. RESULTS: The meta-analysis, including 10 prospective studies, with a total of 19,709 participants and 4,480 cases, detected a significant dose-response association of IL-6 levels with type 2 diabetes risk (relative risk [RR] 1.31 [95% CI 1.17–1.46]). For CRP, the meta-analysis involving 22 cohorts, with a total of 40,735 participants and 5,753 cases, showed that elevated CRP levels were significantly associated with increased risk of type 2 diabetes (1.26 [1.16–1.37]), with the absence of publication bias. Sensitivity and subgroup analyses further supported the associations. CONCLUSIONS: This meta-analysis provides further evidence that elevated levels of IL-6 and CRP are significantly associated with increased risk of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Prospective studies indicate that raised concentrations of IL-6 and CRP in the circulation are associated with increased risk of future T2DM 42.”
From Type 2 diabetes mellitus and psychological stress — a modifiable risk factor (2017) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
PearsonT, A., MensahG, A., & AlexanderR, W. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00016 · Cited by 2,937
Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R., & Rushton, L. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.010 · Cited by 2,053
Microvascular and Macrovascular Complications of Diabetes
Fowler, M. J. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.2.77 · Cited by 1,954
Medzhitov, R. M., & Janeway, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430506 · Cited by 1,827
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–818 of 818
Ullah, M. F., Mir, R., Albalawi, K. S., Alshehri, Y. A., Alahmadi, R. K., Alshamrani, Y. A., Javid, J., Jalal, M. M., Altayar, M. A., & Elfaki, I. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00573-7
Stevens, M., Ayine, M., Gooding, K. M., Shore, A. C., Marqueti, P. V., & Oltean, S. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/2840106
Lévêque, C. (2024) · theses.fr (ABES) · doi:10.70675/0d961065ze6e6z464fz8e74zd9c653b2325f
Spezia, P. G., Cappelli, S., Minosse, C., Focosi, D., Parenti, M., Brunetti, M., Gliozzo, G., Ciccarelli, G., Carciero, L., Giuseppe, G. D., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-47810-1
Kandar, D. K., Killi, K., & Chakrabarti, D. (2026) · Journal of Medical Case Reports · doi:10.1186/s13256-026-06059-y
Bao, Y., Lu, S., Yang, W., Liu, X., Ge, W., Liu, G., Cai, W., Chen, L., & Wang, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-9858751/v1
Zoller, A. R., Athinarayanan, S. J., Tieghem, M. R. V., Adams, R. N., Roberts, C. G. P., Volek, J. S., Phinney, S. D., & McKenzie, A. L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1839029
Plasma proteomics analysis of vitamin C supplementation in people with type 2 diabetes
Grunsven, T. V., Wadley, G. D., & Mason, S. A. (2026) · Nutrition and Diabetes · doi:10.1038/s41387-026-00447-5
Robertson, C. M., Mercado-Evans, V., Larson, A. B., Branthoover, H., Ottinger, S., Mejia, M. E., Hameed, Z. A., Gonzalez, L. A., Serchejian, C., Ogilvie, L., et al. (2026) · mSphere · doi:10.1128/msphere.00027-26
Esfandiari, A. H., Ghahvechi, H., Mehrzad, M., Mobarezi, Z., Abolbashari, S., Meshkat, Z., Ghayour-Mobarhan, M., Esmaily, H., Moohebati, M., & Darroudi, S. (2026) · European journal of medical research · doi:10.1186/s40001-026-04876-x
Multiple 24-Hour Urinary Sodium and Potassium Excretions and Type 2 Diabetes Incidence
Zhu, S., Zhang, X., Hamaya, R., Li, Y., Zhang, Y., Sun, Q., Curhan, G. C., Rimm, E. B., Willett, W. C., Hu, F. B., et al. (2026) · Diabetes Care · doi:10.2337/dc25-2561 · Cited by 1
Self-citationPerspective Chapter: Pro-Inflammatory Cytokines in Type 2 Diabetes – Mechanisms and Applications
Nouh, A. M., Alalem, A. M., Younis, M. Y. G., Ali, A. M., & Hamad, S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016700
Yang, R., Yang, R., Zhang, H., Yang, Y., Shi, Y., & Liu, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1902640
Self-citationElshari, Z. S., Abdulmawala, A. S., & Masud, K. S. A. (2026) · Derna Academy Journal for Applied Sciences · doi:10.71147/427prn62
Adolescent Depressive Symptoms and Adult Functioning Within Major U.S. Racial Groups
Millwood, S. N. (2026) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2026.175
Li, T., Yu, Y., Liu, C., Liu, Z., Tan, Q., & Li, W. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1867760
Metadata
- Authors
- Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P., & Liu, L.-G.
- Affiliations
- Shandong University (CN)
- Huazhong University of Science and Technology (CN)
- Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-12-11
- Volume
- 36
- Issue
- 1
- Pages
- 166-175
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3526249
- OpenAlex
- W2136759091
- Cited by
- 820
- References
- 43
- Citations by year
- 2026: 28 · 2025: 63 · 2024: 79 · 2023: 68 · 2022: 68 · 2021: 72 · 2020: 100 · 2019: 78 · 2018: 61 · 2017: 66 · 2016: 48 · 2015: 45 · 2014: 32 · 2013: 11 · 2012: 1
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- type 2 diabetes, interleukin-6, C-reactive protein, inflammatory markers, diabetes risk, dose-response relationship, inflammation
- MeSH terms
- C-Reactive Protein, Diabetes Mellitus, Type 2, Humans, Risk Factors, Biomarkers, Interleukin-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
